We showed that sorafenib rapidly blocked the catalytic activity of MKNKs, which can promote tumor progression by phosphorylating eIF4E, associated with efficient translation of several oncogenes43,44, and through other mechanisms as well61. This evidence concerns the gene EIF4E and neoplasm.